I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...

The advantage of Python is that you can apply operations to larger datasets with hundreds, even thousands, of data points ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Intensity Therapeutics shares plunged 31.9% after-hours following the publication of Phase 1/2 trial results for its cancer ...

Detailed price information for Phathom Pharmaceuticals Inc (PHAT-Q) from The Globe and Mail including charting and trades.

The biopharmaceutical firm Viking Therapeutics approaches a critical juncture as it prepares to unveil new clinical findings for its obesity treatment candidate, VK2735. These highly anticipated ...

APL is fusing its analytic and cutting-edge AI capabilities into a forward-leaning incubator, known as GenWar Lab, that ...

In exploratory analysis in patients treated at a dose that was greater than 40% of total tumour ... Intensity’s stock jumped 394.4% when the data was released, from a 29 October close of $0.27 to ...

The published manuscript detailed the safety and efficacy results of INT230-6, Intensity’s intratumoral therapy for treating metastatic or refractory cancers. The data showed a 75% disease control ...

Findings further demonstrate the effectiveness of Roche's approved medicines in advancing treatment standards for people with blood disorders Data from innovative pipeline signals progress ...